How Should We Evaluate Outcomes for Use of Biologics in the Knee?

  • Christopher LaPrade, Evan James, Robert LaPrade, Lars Engebretsen
  • The Journal of Knee Surgery, September 2014, Thieme Publishing Group
  • DOI: 10.1055/s-0034-1390028

Evaluating the Effects of Biologic Treatments in the Knee.

What is it about?

This article provides clear definitions of the specific subjective and objective outcomes we need to evaluate biologics for knee pathology

Why is it important?

This article is important because biologics are increasingly used to treat knee pathology. Further definition of ways to objectively and subjectively evaluate the effects of biologics will better define how biologics work and which biologic treatments do not work to treat knee pathology.


Dr Robert F LaPrade
Steadman Philippon Research Institute

This article serves as a base in the bottom of the research pyramid to understanding how to use biologics for treating knee pathology.

Read Publication

The following have contributed to this page: Dr Robert F LaPrade and Dr. Robert F. LaPrade